Paper37646133
ICAM-1-decorated extracellular vesicles loaded with miR-146a and Glut1 drive immunomodulation and hinder tumor progression in a murine model of breast cancer.
Duarte-Sanmiguel S and 21 others. Biomater Sci, 2023. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. ICAM-1-decorated extracellular vesicles loaded with miR-146a and Glut1 drive immunomodulation and hinder tumor progression in a murine model of breast cancer. Papers, record 37646133. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37646133
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ICAM-1-decorated extracellular vesicles loaded with miR-146a and Glut1 drive immunomodulation and hinder tumor progression in a murine model of breast cancer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Vesicles | Major topic |
| MicroRNAs | Major topic |
| Glucose Transporter Type 1 | Major topic |
| Intercellular Adhesion Molecule-1 | Major topic |
| Immunomodulation | Major topic |
| Animals | |
| Female | |
| Mice | |
| Breast Neoplasms | |
| Disease Progression | |
| Cell Line, Tumor | |
| Mice, Inbred BALB C | |
| Humans | |
| Myeloid-Derived Suppressor Cells |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DP2 EB028110 | NIBIB NIH HHS | United States | DP2EB028110 | PubMed and NIH |
Source NIH RePORTER
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28187290 | Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. | Cell | 2017 | https://conductscience.org/library/papers/28187290 | PubMed |
| 2 | 23532593 | Polarization and reprogramming of myeloid-derived suppressor cells. | J Mol Cell Biol | 2013 | https://conductscience.org/library/papers/23532593 | PubMed |
| 3 | 27757311 | Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27757311 | PubMed |
| 4 | 27074905 | Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy. | Sci Rep | 2016 | https://conductscience.org/library/papers/27074905 | PubMed |
| 5 | 25746680 | Tumor cell secretion of soluble factor(s) for specific immunosuppression. | Sci Rep | 2015 | https://conductscience.org/library/papers/25746680 | PubMed |
| 6 | 19287097 | WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19287097 | PubMed |
| 7 | 28785092 | Topical tissue nano-transfection mediates non-viral stroma reprogramming and rescue. | Nat Nanotechnol | 2017 | https://conductscience.org/library/papers/28785092 | PubMed |
| 8 | 32419350 | Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment. | Adv Biosyst | 2020 | https://conductscience.org/library/papers/32419350 | PubMed |
| 9 | 18328424 | Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18328424 | PubMed |
| 10 | 20702612 | A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/20702612 | PubMed |
| 11 | 26226356 | miRWalk2.0: a comprehensive atlas of microRNA-target interactions. | Nat Methods | 2015 | https://conductscience.org/library/papers/26226356 | PubMed |
| 12 | 20404138 | Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20404138 | PubMed |
| 13 | 24492615 | Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24492615 | PubMed |
| 14 | 30659108 | Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1. | J Immunol | 2019 | https://conductscience.org/library/papers/30659108 | PubMed |
| 15 | 23849857 | Reactive oxygen species in the activation of MAP kinases. | Methods Enzymol | 2013 | https://conductscience.org/library/papers/23849857 | PubMed |
| 16 | 29709256 | Turning Cold Tumors Hot by Blocking TGF-β. | Trends Cancer | 2018 | https://conductscience.org/library/papers/29709256 | PubMed |
| 17 | 35014204 | Designer Extracellular Vesicles Modulate Pro-Neuronal Cell Responses and Improve Intracranial Retention. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/35014204 | PubMed |
| 18 | 19197294 | Myeloid-derived suppressor cells as regulators of the immune system. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19197294 | PubMed |
| 19 | 24197130 | Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. | Cancer Res | 2014 | https://conductscience.org/library/papers/24197130 | PubMed |
| 20 | 26689540 | Functions of miR-146a and miR-222 in Tumor-associated Macrophages in Breast Cancer. | Sci Rep | 2015 | https://conductscience.org/library/papers/26689540 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936663 | Extracellular Vesicles in Breast Cancer: Immunomodulation, Biomarkers, and Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42936663 | PubMed |
| 42233165 | Repurposing the skin to heal the body: Tissue Nanotransfection (TNT) as a therapeutic platform. | Med X | 2026 | https://conductscience.org/library/papers/42233165 | PubMed |
| 42030165 | Isolation of Extracellular Vesicles From Mouse Brown Adipose Tissue Secretome Using Size-Exclusion Chromatography. | FASEB J | 2026 | https://conductscience.org/library/papers/42030165 | PubMed |
| 41975457 | Targeting phase separation: a new strategy to disrupt the stromal-immune axis in colorectal cancer. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41975457 | PubMed |
| 41950328 | Vasculogenic tissue nanotransfection accelerates functional recovery after peripheral nerve injury. | Sci Adv | 2026 | https://conductscience.org/library/papers/41950328 | PubMed |
| 41303767 | Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41303767 | PubMed |
| 41200107 | Developing and optimizing a biocompatible tauopathy model using extracellular vesicle-mediated gene delivery. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41200107 | PubMed |
| 41190106 | Noncoding RNA-Mediated Regulation of Myeloid-Derived Suppressor Cells in Cancer. | Cancer Manag Res | 2025 | https://conductscience.org/library/papers/41190106 | PubMed |
| 41132510 | Extracellular vesicles as vehicles for small non-coding RNA therapeutics: standardization challenges for clinical translation. | Extracell Vesicles Circ Nucl Acids | 2025 | https://conductscience.org/library/papers/41132510 | PubMed |
| 41036223 | Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41036223 | PubMed |
| 40606909 | Tissue nanotransfection and cellular reprogramming in regenerative medicine and antimicrobial dynamics. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40606909 | PubMed |
| 40574998 | Multiplex Detection of Biomarkers Empowered by Nanomaterials. | Precis Chem | 2025 | https://conductscience.org/library/papers/40574998 | PubMed |
| 40524679 | Rewiring cell identity in vivo: the emerging role of extracellular vesicles. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/40524679 | PubMed |
| 40353080 | Immune cell-derived exosomal non-coding RNAs in tumor microenvironment: Biological functions and potential clinical applications. | Chin J Cancer Res | 2025 | https://conductscience.org/library/papers/40353080 | PubMed |
| 39696346 | Exosomes and breast cancer angiogenesis; Highlights in intercellular communication. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39696346 | PubMed |
| 39491627 | Tissue nano-transfection of antimicrobial genes drives bacterial biofilm killing in wounds and is potentially mediated by extracellular vesicles. | J Control Release | 2024 | https://conductscience.org/library/papers/39491627 | PubMed |
| 39044286 | Quality control and validation of extracellular vesicles isolated from cultured human breast cancer cells. | BMC Res Notes | 2024 | https://conductscience.org/library/papers/39044286 | PubMed |
| 38583365 | Engineered extracellular vesicle-based gene therapy for the treatment of discogenic back pain. | Biomaterials | 2024 | https://conductscience.org/library/papers/38583365 | PubMed |
| 38276735 | Tissue Nanotransfection Silicon Chip and Related Electroporation-Based Technologies for In Vivo Tissue Reprogramming. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/38276735 | PubMed |
| 38263860 | Truncated PD1 Engineered Gas-Producing Extracellular Vesicles for Ultrasound Imaging and Subsequent Degradation of PDL1 in Tumor Cells. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38263860 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37646133
GET https://conductscience.org/api/papers/v1/37646133/authors?page=2